These results, and the fact that genetic inactivation of LRRK2 kinase activity showed a protective effect against such a toxic phenotype, suggest that an alteration in LRRK2 kinase activity is potentially involved in the neurotoxic and pathogenic mechanisms of LRRK2‐PD. The gene discussed is LRRK2; the disease is Parkinson disease.